COVID-19 & CancerFreeGuest Editorial Let’s not form blue ribbon panels to study disparities in COVID-19 deathsInstead, let’s find the will to act May 22, 2020Vol.46 No.21By Robert A. Winn and Katherine Y. Tossas
FreeObituary Oncology pioneer John W. Yarbro dies at 88 May 15, 2020Vol.46 No.20By Eric T. Rosenthal and Donald L. "Skip" Trump
FreeObituary The Class of 1983; Remembering Josh Fidler May 15, 2020Vol.46 No.20By Irwin H. Krakoff and Rosemary Mackey
FreeObituary Isaiah Fidler, founder of MD Anderson Department of Cancer Biology, dies at 83 May 15, 2020Vol.46 No.20
COVID-19 & CancerFreeGuest Editorial SARS-CoV-2 and oncology drugsWhat do we mean when we talk about value? May 15, 2020Vol.46 No.20By Garth W. Strohbehn, Daniel A. Goldstein and Mark J. Ratain
Free NCI BSA approves 11 new and reissue concepts, defers one May 15, 2020Vol.46 No.20By Alexandria Carolan
COVID-19 & CancerFreeNCI Sharpless: COVID-19 threatens to reverse long-running trend of decreasing cancer mortality May 15, 2020Vol.46 No.20By Matthew Bin Han Ong
COVID-19 & CancerFree With $306M for serology research, NCI mobilizes labs, academic centers, grantees, contractors, and SBIR May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Nancy Davidson describes plans for reopening the Seattle Cancer Care Alliance as COVID-19 wave recedes May 15, 2020Vol.46 No.20By Paul Goldberg
Conversation with The Cancer LetterCOVID-19 & CancerFree Lessons from COVID-19:Leaders of six cancer centers in the DMV area tell us about caseloads, the outlook—and impact May 08, 2020Vol.46 No.19By Matthew Bin Han Ong
